Background: Myasthenia gravis (MG) is a specific autoimmune disease characterized by weakness and fatigue. MG may affect also the respiratory muscles causing symptoms that may vary from dyspnea on severe exertion to dyspnea at rest. This study was undertaken in order to determine the effects of respiratory muscle training on respiratory muscle performance, spirometry data and the grade of dyspnea in patients with moderate to severe generalized MG. Methods: Eighteen patients with MG were studied and divided into 2 groups: Group A included 10 patients (3 males and 7 females aged 29-68) with moderate MG, and Group B that included 8 patients (5 males and 3 females aged 21-74) with severe MG. Patients in Group A received both inspiratory and expiratory muscle training for 1/2 h/day, 6 times a week, for 3 months, while patients in Group B followed the same protocol but had inspiratory muscle training only. Results: Mean PI max increased significantly from 56.6 ± 3.9 to 87.0 ± 5.8 cm H 2 0 (p < 0.001) in Group A, and from 28.9 ± 5.9 to 45.5 ± 6.7 cm H 2 0 (p < 0.005) in Group B. The mean PE max also increased significantly in patients in Group A, but remained unchanged in the patients in Group B. The respiratory muscle endurance also increased significantly, from 47.9 ± 4.0 to 72.0 ± 4.2%, p < 0.001, in patients of Group A, and from 26.0 ± 2.9 to 43.4 ± 3.8, p < 0.001, in patients in Group B. The improved respiratory muscle performance was associated with a significant increase in the FEV, values, and in the FVC values, in patients of both groups. Mean dyspnea index score also increased significantly from 2.6 ± 0.8 to 3.6 ± 0.4 (p < 0.005) in Group A, and from 0.7 ± 0.2 to 2.0 ± 0.2 (p < 0.001) in Group B. Conclusions: Specific inspiratory threshold loading training alone, or combined with specific expiratory training, markedly improved respiratory muscle strength and endurance in patients with MG. This improvement in respiratory muscle performance was associated with improved lung function and decreased dyspnea. Respiratory muscle training may prove useful as a complementary therapy with the aim of reducing dyspnea symptoms, delay the breathing crisis and the need for mechanical ventilation in patients with MG. RESUME: Entrainement des muscles respiratoires chez les patients porteurs d'une myasthenic grave moderee a severe. Introduction: La myasthenic grave (MG) est une maladie autoimmune caracterisee par de la faiblesse et de la fatigue. La MG peut atteindre egalement les muscles respiratoires causant des symptomes allant de la dyspnee a l'exercice intense a la dyspnee au repos. Le but de cette etude etait de determiner les effets de I'entrainement des muscles respiratoires sur la performance des muscles respiratoires, les donnees de la spirom6trie et le grade de la dyspnee chez les patients ayant une MG generalisee de moderee a severe. Methodes: Dix-huit patients souffrant de MG ont ete etudies et divisds en 2 groupes: le groupe A comprenait 10 patients (3 hommes et 7 femmes ages de 29 a 68 ans) ayant une MG moderee et le groupe B comprenait 8 patients (5 hommes et 3 femmes ag6s de 21 a 74 ans) ayant une MG severe. Les patients du groupe A ont recu un entrainement des muscles pour l'inspiration et 1'expiration pendant 1/2 heure par jour, 6 jours par semaine, pendant 3 mois, et les patients du groupe B ont suivi le meme protocole, mais sans entratnement des muscles expiratoires. Resultats: Le PI max augmentait significativement de 56. ± 63.9 a 87.0 ± 5.8 cm H 2 0 (p < 0.001) dans le groupe A et de 28.9 ± 5.9 a 45.5 ± 6.7 cm H 2 0 (p < 0.005) dans le groupe B. Le PE max avait egalement augmente de facon significative chez les patients du groupe A, mais etait demeure' inchange chez les patients du groupe B. L'endurance des muscles respiratoires avait egalement augmente de facon significative, de 47.9 ± 4.0 a 72.0 ± 4.2%, p < 0.001, chez les patients du groupe A et de 26.0 ± 2.9 a 43.4 ± 3.8, p < 0.001, chez les patients du groupe B. L'amelioration de la performance des muscles respiratoires 6tait associee a une augmentation significative dans les valeurs du VEMS et dans les valeurs de CVF chez les patients des deux groupes. Le score a l'indice de dyspnee etait egalement augmente de facon significative de 2.6 ± 0.8 a 3.6 ± 0.4 (p < 0.005) dans le groupe A et de 0.7 ± 0.2 a 2.0 ± 0.2 (p < 0.001) dans le groupe B. Conclusions: Uentrainement a un seuil de charge inspiratoire specifique seul ou combine a l'entramement expiratoire specifique ameliore de facon marquee la force des muscles respiratoires et l'endurance des patients atteints de MG. Cette amelioration dans la performance des muscles respiratoires etait associee a une amelioration de la fonction pulmonaire et a une diminution de la dyspnee. L'entramement des muscles respiratoires peut etre un traitement complementaire dont le but est de diminuer les symptomes de dyspnee, de retarder la crise respiratoire et le recours a la ventilation mecanique chez les patients atteints de MG.
LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES due to respiratory muscle involvement depend on the severity of the disease, and may vary from dyspnea on mild to moderate exertion to respiratory failure that require prolonged periods of assisted ventilation. 7 " 9 Anticholinesterase therapy, thymectomy and immunosupression are frequently used in the treatment of MG.' 10 " However, only a few patients will regain normal function with the therapy. 12 It is well established that respiratory muscles can be trained for both strength and endurance like other skeletal muscles and several reviews have been published dealing with ventilatory muscle training. 1315 Its efficacy has been previously shown in normal subjects, 16 quadriplegics, 17 cystic fibrosis, asthma, 18 patients on chronic hemodialysis, 19 patients undergoing open heart surgery 2021 as well as in patients with COPD. 22 However, our research revealed only one study, with a small group of patients, in which the respiratory muscles were trained specifically in patients with MG. 23 This study was designed in order to assess the effects of respiratory muscle training (RMT) on inspiratory and expiratory muscle strength, endurance, lung function, and dyspnea, in a population of adult MG patients.
METHODS

Patients
Eighteen patients with MG (10 women and 8 men) 21 to 74 yr age (mean ± SEM, 45.4 ± 3.7 yr) were included in the study. The diagnosis of MG was based on a history of fatiga-ble muscle weakness, by a decremental response of the amplitude of the motor response to repetitive nerve stimulation and by a positive edrophonium test. 4 Acetylcholine receptor antibodies were investigated in 14 patients, and were present in 12.-All had some degree of dyspnea, and were classified functionally according to the Osserman grade 24 (Table 1 ). The patients were divided into 2 groups: 10 patients that were mildly and moderately affected (of Osserman classifiction II and III) (Group A) and received both inspiratory muscle and expiratory muscle training, and 8 patients with severe MG (Osserman classification IV) (Group B) received inspiratory muscle training only. All patients were treated by anticholinesterase, 13 had thymectomy, and 11 received steroids (prednisone 20-40 mg on alternate days). No change in drug therapy was allowed during the study. Two patients, in Group B (No. 1, 2) were treated with supplemental oxygen before training.
Spirometry Pulmonary functions were assessed by spirometry, performed before, 1 month and 3 months following RMT. The forced vital capacity (FVC) and the forced expiratory volume in one second (FEV,) were measured 3 times on a computerized spirometer (Compact, Vitalograph, Buckingham England) and the best trial is reported.
Respiratory muscle strength Respiratory muscle strength was assessed by measuring the maximal inspiratory mouth pressure (PI max ) at residual volume (RV) and the maximal expiratory mouth pressure (PE mox ) at total lung capacity (TLC) as previously described by Black and Hyatt. 25 The value obtained from the Ila  lib  III  lib  III  III  lib  III   IV  IV  IV  IV  IV  IV  IV  IV   dyspnea   4  5  3 best of at least 3 efforts was used. Dynamic inspiratory muscle strength Dynamic inspiratory muscle strength was assessed by measuring the maximal inspiratory mouth pressure (PI max ) at residual volume (RV) every 30 seconds and up to 6 measurements.
Grade of MG lib lib
Inspiratory muscle endurance To determine inspiratory muscle endurance a device similar to that proposed by Nickerson and Keens 26 was used. Subjects inspired through a two-way Hans-Rudolph valve whose inspiratory port was connected to a chamber and plunger to which weights could be added externally. Inspiratory elastic work was then increased by the progressive addition of 25 to 100 g weights at 2-min intervals, as was previously described by Martyn and coworkers, 27 until the subjects were exhausted and could no longer inspire. The pressure achieved with the heaviest load (tolerated for at least 60 s) was defined as the peak pressure (P m Peak).
Training protocol Subjects in both groups trained daily, six times a week, each session consisted of 1/2 hour training, for three months. The training was performed under the supervision of a physio-therapist.
Inspiratory muscle training (IMT) and Expiratory muscle training (EMT)
The subjects received IMT with a threshold inspiratory muscle trainer (Threshold™ Inspiratory Muscle Trainer, Healthscan, NJ) and EMT with the same trainer held on the reversed side. Patients in group A received IMT for the first 15 minutes of each session and EMT for the last 15 minutes. The subjects started breathing at a resistance equal to 15% of their PI max or PE max , for one week. The resistance was then increased incrementally, 5% each session, to reach 60% of their P^max' o r P^max' a t t n e e n^ °f t n e f' rst m o n t n -IMT and EMT were then continued, for the next two months at this level of resistance. Patients in Group B received IMT for the whole session and followed the same protocol.
Dyspnea index The clinical rating of dyspnea was graded by a physician, who was blinded to the kind of treatment the patients have received, using the dyspnea index (Appendix A), that was based on two components evoking dyspnea: magnitude of the task which considers mainly isotonic work; and magni- tude of effort which considers mainly isometric work. The physician selected one of five grades of dyspnea for each of the two components and the mean of the two numbers is reported. The patients in Group B all had some degree of leg and arm weakness. The physician who graded their degree of dyspnea tried to isolate this weakness from true dyspnea.
Statistical analysis
The effect of training on lung function, arterial blood gases and repiratory muscle performance was analysed using the twoway repeated measures analysis of variance (Anova). When the overall Anova was significant, post hoc comparisons were made. Chi-square (degree of freedom-1) statistics were used to compare changes in dyspnea index. Pearson correlation coefficients and linear regression analysis allowed comparison between the two regression lines in the dynamic inspiratory muscle strength test. Significance was accepted if p < 0.05. 
RESULTS
Respiratory muscle strength
The mean effect of the training on the respiratory muscle strength is shown in Figure 1 . All patients, in both Group A and Group B, showed an increase in the inspiratory muscle strength, as was assessed by measuring the PI max at RV. Mean PI max increased significantly from 56.6 ± 3.9 to 87.0 ± 5.8 cm H 2 0 (p < 0.001) in Group A, and from 28.9 ± 5.9 to 45.5 ± 6.7 cm H 2 0 (p < 0.005) in Group B. The mean PE max also increased significantly in patients in Group A, but remained unchanged in the patients in Group B (from 71.5 ± 3.5 to 86.6 ± 4.7 cm H 2 0, p < 0.05, and from 28.2 ± 2.6 to 30.1 ± 2.8 cm H 2 0, respectively).
Respiratory muscle endurance The respiratory muscle endurance, as expressed by the relationship between P m Peak and PI mal (PI max following training) also increased significantly, from 47.9 ± 4.0 to 72.0 ± 4.2%, p < 0.001, in patients of Group A, and from 26.0 ± 2.9 to 43.4 + 3.8, p < 0.001, in patients in Group B (Figure 2) .
Dynamic inspiratory muscle strength The dynamic inspiratory muscle strength test was performed in order to assess the progressive fatigue of the inspiratory muscles while conducting the maximal inspiratory mouth pressure maneuver 6 times with 30 seconds interval. The dynamic test was performed only in patients in Group A. It was found that not only the PI max was significantly improved, for every single measurement, but the decline in PI max that was noted for repetitive measurements, was significantly attenuated (difference between regression lines-p < 0.05) (Figure 3) .
Spirometry The effect of the training programs on lung function data are shown in Figure 4 . There was a significant increase in the FEV, values, from 77.3 ± 2.6 to 88.0 ± 2.2% of predicted normal values, p < 0.005, in patients of Group A, and from 28.9 ± 5.9 to 45.5 ± 6.7, p < 0.005, in patients in Group B, and in the FVC values, from 76.2 ± 1.8 to 88.1 ± 2.0, p < 0.005, in patients of Group A, and from 35.4 ± 5.6 to 53.9 ± 5.0, p < 0.001, in patients in Group B.
Arterial blood gases P a 0 2 and PaC0 2 remained almost unchanged, following training, in Group A. However, mean Pa0 2 increased significantly, from 63.8 ± 3.7 to 72.7 ± 4.0 Tor (p < 0.005), and the mean PaC0 2 decreased significantly, from 55.3 ± 4.6 to 49.8 ± 3.6 Tor (p < 0.05) ( Figure 5 ).
Dyspnea index The clinical rating of dyspnea was assessed before and after the training period. The mean dyspnea index score increased significantly from 2.6 ± 0.8 to 3.6 ± 0.4 (p < 0.005) in Group A, and from 0.7 ± 0.2 to 2.0 ± 0.2 (p < 0.001) in Group B. The results of the individual dyspnea index score are shown in Figure 6 . All patients but one (in Group A) improved their dyspnea index score significantly.
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DISCUSSION
In our study, we found that specific inspiratory threshold loading training alone, or combined with specific expiratory training, 6 times a week, for 1/2 hour each session, for 3 months, markedly improved respiratory muscle strength and endurance in patients with MG. This improvement in respiratory muscle performance was associated with improved lung function and decreased dyspnea. Our findings are weakened by the lack of a control group. However, the number of patients that could be recruited for the study was limited, and we preferred to have a significant number of patients in the training group, instead of randomizing them between a study group and a control group.
Respiratory muscle performance is reduced in MG. Mier-Jedrzejowicz and associates 6 have already demonstrated, in a study of 17 patients with MG, that the mean PI max was 52% and the mean PE max was 54% of predicted normal values. In addition, PI max and PE max significantly improved following the administration of an anticholinesterase agent, suggesting that the reduced strength of the respiratory muscles was due to MG.
The weakness of the respiratory muscles in patients with MG is usually symptomatic, depending on the severity of the disease. It may vary from dyspnea only with a vigorous effort to dyspnea that is apparent at rest. 9 A number of studies have been carried out in order to correlate dyspnea and respiratory muscle performance. It was well documented that the intensity of breathlessness is related to the activity and the strength of the inspiratory muscles. 28 In patients with MG, VC is usually low due to reduced inspiratory capacity and expiratory reserve volume. The reduction of lung volume may lead to patchy areas of atelectasis and consequently to ventilation-perfusion mismatch APPENDIX A and hypoxemia. Hypercapnia may also occur as a result of hypoventilation secondary to fatigue of the inspiratory muscles. Hypoxemia, with or without hypercapnea, may lead to increased work of breathing. In addition, previous reports suggest that patients with MG may have reduced pulmonary 29 and chest wall 30 compliance, which by itself increases the work of breathing. Their increased work combined with impaired respiratory muscle function accounts for the patients' sense of dyspnea. Therefore, specific respiratory muscle training seems to play an important role in the management of patients with MG, as an addition to common acceptable medical therapy. If dyspnea is related to the increased work, combined with impaired function of the respiratory muscles, then improved strength and endurance of those muscles must be followed by improvment in symptoms.
The majority of patients treated with anticholinesterase will improve significantly. 12 However, most of them will remain with impaired respiratory muscle perfomance and will continue to deteriorate. In addition, overdosage with anticholinesterase treatment may result in increased muscle weakness. Corticosteroids may also improve symptoms in patients with MG; however, there is always the risk of exacerbating muscle weakness, because of myopathic effects. 31 Patients with MG, not only may have variable degree of dyspnea, but may exhibit respiratory failure either spontaneously or secondary to intercurrent infection, emotional trauma, surgery (especially after thymectomy) or other complications. 32 Improved strength and endurance of the inspiratory muscles may also delay the onset of respiratory muscle fatigue and respiratory failure in those patients.
Leith and Bradley, 16 were the first to report that respiratory muscle can be specifically trained in normal persons. Later,
Dyspea index
Magnitude of task
Magnitude of effort
Grade 4
Extraordinary. Becomes short of breath only with extraordinary activity, such as carrying very heavy loads on the level, lighter loads uphill, or running. No shortness of breath with ordinary task.
Grade 3
Major. Becomes short of breath only with such major activities as walking up a steep hill, climbing more than three flights of stairs, or carrying a moderate load on the level.
Grade 2
Moderate. Becomes short of breath with moderate or average tasks, such as walking up a gradual hill, climbing less than three flights of stairs, or carrying a light load on the level.
Grade 1 Light. Becomes short of breath with activities, such as walking on the level, washing, standing or shopping.
Grade 0 No task. Becomes short of breath at rest, while sitting, or lying down.
Extraordinary. Becomes short of breath only with the greatest imaginable effort. No shortness of breath with ordinary effort.
Major. Becomes short of breath with effort distinctly submaximal, but of major proportion. Tasks performed without pause unless the task requires extraordinary effort that may be performed without pause.
Moderate. Becomes short of breath with moderate effort. Tasks performed with occasional pause and requiring longer to complete than the average person.
Light. Becomes short of breath with little effort.
No effort. Becomes short of breath at rest, while sitting, or lying down.
